Orthogon Therapeutics is Drug Discovery in United States that focus on normal quality business. Founded in 2012. They cover business area such as Provider, drug design service, critical need, drug discovery, bridge frontier research, formal drug development, innovative technology, small molecule, challenge, drug target, client, normal quality medicinal lead molecule.
2012
( 12 years old in 2024 )
Normal Quality
-
960 Turnpike Street
Unit 10
Canton, MA 02021
United States
Private
Providerdrug design servicecritical needdrug discoverybridge frontier researchformal drug developmentinnovative technologysmall moleculechallengedrug targetclientnormal quality medicinal lead molecule
* We use standard office opening hours in near Orthogon Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Orthogon Therapeutics is Drug Discovery business from United States that founded in 2012 (12 years old in 2024), Orthogon Therapeutics business is focusing on Normal Quality.
Orthogon Therapeutics headquarter office and corporate office address is located in 960 Turnpike Street Unit 10 Canton, MA 02021 United States.
Orthogon Therapeutics was founded in United States.
In 2024, Orthogon Therapeutics is currently focus on normal quality sector.
Above is snippet of Google Trends for "normal quality" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Orthogon Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
